Led the flagship Organoid project (EUR 3M) on intestinal cancer organoids, plus INTENS (tissue engineering), EuroStemCell, and BRCANCER/HGSOC on cancer modeling with organoids.
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
Dutch national academy governing top research institutes in organoid biology, neuroscience, and European open science infrastructure.
Their core work
KNAW is the Royal Netherlands Academy of Arts and Sciences, an umbrella organization governing several leading Dutch research institutes including the Hubrecht Institute for developmental biology. Their core scientific strength lies in organoid biology, stem cell research, neuroscience, and gene regulation, while simultaneously playing a major role in building and governing European research infrastructures for open science and data management. They bridge fundamental life sciences with digital infrastructure, making them both a top-tier lab and a policy-shaping institution for how European research data is shared and preserved.
What they specialise in
Active across OpenAIRE2020, EUDAT2020, CORBEL, EHRI, EOSC-related projects, SERISS, and hosted the 2016 ESFRI Roadmap launch event (KNAW-ESFRI).
Participated in the Human Brain Project (HBP SGA1), led INSOMNIA (EUR 1.9M on sleep and aging), CoordinatedDopamine, switchBoard retinal processing, and PREDACTION on action prediction.
Coordinated EHRI (European Holocaust Research Infrastructure, EUR 2.4M), participated in PARTHENOS, HaS-DARIAH, CESSDA-SaW, and LONGPOP for population data analysis.
Coordinated RNAREG (EUR 1.5M on single-molecule gene expression), with recent keywords showing gene therapy and chromatin research across multiple ERC grants.
Coordinated FamilyComplexity and HInDI (EUR 1.5M on historical industrialization dynamics), with keywords covering intergenerational solidarity and social stratification.
How they've shifted over time
In 2015–2018, KNAW's work centered on brain simulation and neuroinformatics (Human Brain Project), building open access and e-infrastructure platforms (OpenAIRE2020, EUDAT2020), and establishing research infrastructure networks across disciplines. From 2019 onward, their focus shifted decisively toward organoid biology, gene therapy, and optogenetics on the life sciences side, while their infrastructure work matured into EOSC, FAIR data, and semantic web technologies. The trajectory shows a move from broad infrastructure-building toward more targeted translational biology combined with next-generation data governance.
KNAW is converging on translational organoid and gene therapy research while deepening its role as a governance hub for European open science infrastructure — expect future projects at the intersection of FAIR data and precision medicine.
How they like to work
KNAW operates as both a project leader and a trusted consortium partner in roughly equal measure (53 coordinated vs 62 as participant), which is unusual for a research organization of this size — most lean heavily one way. With 874 unique partners across 59 countries, they function as a major network hub rather than working with a fixed set of collaborators. This breadth means they bring connections and credibility to any consortium, and their experience coordinating large infrastructure projects makes them effective at managing complex multi-partner work.
KNAW has worked with 874 distinct partner organizations across 59 countries, making it one of the most connected research institutions in H2020. Their network is pan-European at its core but extends globally, with particularly strong ties in research infrastructure and life sciences communities.
What sets them apart
KNAW is rare in combining world-class wet-lab biology (organoids, stem cells, gene regulation) with deep involvement in research infrastructure governance and open science policy. Where most life science institutes focus purely on research, KNAW also shapes how European research data is stored, shared, and made FAIR — giving partners access to both scientific excellence and infrastructure influence. Their Academy status in the Netherlands means they carry institutional weight that opens doors at the policy level, making them an especially strong coordinator for projects that need both scientific credibility and political traction.
Highlights from their portfolio
- OrganoidLargest single grant (EUR 3M, coordinated) — pioneered microbiome and immune interaction research using intestinal cancer organoids, a technique KNAW helped develop.
- EHRICoordinated this EUR 2.4M European Holocaust Research Infrastructure, demonstrating KNAW's unique ability to lead sensitive cross-border heritage digitization at scale.
- INSOMNIAEUR 1.9M ERC-level grant coordinated by KNAW, bridging neuroscience and aging research with direct intervention potential — shows their translational ambition.